Advanced Imaging in Chagas Heart Disease: from diagnosis to sudden death risk stratification.

Hugo Rodriguez-Zanella, Jose Luis Salas-Pacheco, Gabriela Melendez-Ramirez, Jose Antonio Arias-Godínez, Nydia Avila-Vanzzinni, Maria Eugenia Ruiz-Esparza, Juan Francisco Fritche Salazar, Jesus Antonio Blanco Figueroa, Erick Alexánderson-Rosas

Abstract


Chagas disease constitutes a relatively prevalent condition in Latin America and is increasing worldwide. With a wide spectrum of clinical subsets. Imaging modalities are critical for adequate diagnosis, staging and prognosis of this entity. Currently Echocardiography and Cardiac Magnetic Resonance are the most valuable techniques for this purpose. Evidence for both modalities has increased in the last years, as the role of advanced techniques such as Speckle Tracking Echocardiography has been explored we aim to review the evidence of advanced imaging in the spectrum of patients with Chagas Heart Disease.


Keywords


Chagas Disease, Advanved Imaging, Late Gadollinium enhancement, Strain Imaging.

Full Text:

PDF

References


Stanaway J, Roth G. The Burden of Chagas Disease: Estimates and Challenges. Glob Heart. 2015 Sep;10(3):139-44. doi: 10.1016/j.gheart.2015.06.001.

Gascon J, Bern C, Pinazo MJ. Chagas Disease in Spain, the United States and other non-endemic countries. Acta Trop 2010;115:22-27. doi: 10.1016/j.actatropica.2009.07.019

Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009; 49: e52–54. doi: 10.1086/605091

Sabino EC, Ribeiro AL, Salemi VM, et al., for the National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors. Circulation 2013;127:1105–15. doi: 10.1161/CIRCULATIONAHA.112.123612

Carrasco HA, Parada H, Guerrero L, Duque M, Duran D, Molina C. Prognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas’ disease. Int J Cardiol 1994;43:27-28.

Rassi A Jr, Rassi A, Little W, Xavier S, Rassi S, Rassi A, Rassi G, Hasslocher-Moreno A, Sousa A, Scanavacca I. Development and Validation of a Risk Score for predicting death in Chagas’ Heart Disease. N Eng J Med 2006;355: 799-808. DOI: 10.1056/NEJMoa053241

Andrade JP, Marin-Neto JA, De Paola AAV, et al. I Latin American guidelines for the diagnosis and treatment of Chagas’ heart disease: executive summary. Arq Bras Cardiol 2011;96:434–42.

Rassi Jr A, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375(9723):1388–402. DOI: http://dx.doi.org/10.1016/S0140-6736(10)60061-X

Rossi MA. Microvascular changes as a cause of chronic cardiomyopathy in Chagas’ disease. Am Heart J 1990; 120: 233–36

Marin-Neto JA, Marzullo P, Marcassa C, et al. Myocardial perfusión defects in chronic Chagas’ disease as detected by thallium-201 scintigraphy. Am J Cardiol 1992; 69: 780–84.

Rassi, A., Rassi, S. G. Predictors of mortality in chronic Chagas disease a systematic review of observational studies. Circulation 2007, 115(9), 1101-1108. Doi:10.1161/CIRCULATIONAHA.106.627265

Sousa AC, Marin-Neto JA, Maciel BC, Gallo Junior L, Amorim Dde S, Barreto-Martins LE. Systolic and diastolic dysfunction in the indeterminate, digestive and chronic cardiac forms of Chagas’ disease. Arq Bras Cardiol. 1988;50(5):293–9.

Siciliano APRV, Moreno AH, Sousa AS, Brasil PEA, Holanda MT, Garcia MY, et al. Pattern of diastolic function and its relation to the severity of the clinical form in 902 patients in the chronic phase of Chagas disease. Rev Bras Cardiol 2006;19:75-84. 


Acquatella H, Pérez J, Condado J, Sánchez I. Limited myocardial contractile reserve and chronotropic incompetence in patients with chronic Chagas' disease: assessment by dobutamine stress echocardiography. JACC 1999;33(2)522-529.

Nunes MC, Barbosa MM, Ribeiro AL, Colosimo EA, Rocha MO. Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy. J Am Soc Echocardiogr 2009;22:82-8. 
 doi: 10.1016/j.echo.2008.

Barros MV, Machado FS, Ribeiro AL. Da Costa Rocha MO. Detection of early right ventricular dysfunction in Chagas’ disease using Doppler tissue imaging. J Am Soc Echocardiogr 2002;15: 1197–201. DOI: http://dx.doi.org/10.1067/mje.2002.122966

Nunes Mdo C, Rocha MO, Ribeiro AL, Colosimo EA, Rezende RA, Carmo GA, Barbosa MM. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy. Int J Cardiol. 2008 Jul 21;127(3):372-9

Mor-Avi V, Lang RM, Badano LP, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/ EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr 2011; 24:277–313. doi: 10.1016/j.echo.2011.01.015.

Jasaityte R, Dandel M, Lehmkuhl H, Hetzer R. Prediction of short-term outcomes in patients with idiopathic dilated cardiomyopathy referred for transplantation using standard echocardiography and strain imaging. Transplant Proc 2009;41:277-80. doi: 10.1016/j.transproceed.2008.10.083.

Galli, E., Lancellotti, P., Sengupta, P. P., Donal, E. LV mechanics in mitral and aortic valve diseases: value of functional assessment beyond ejection fraction. JACC: Cardio Imag, 2014: 7(11), 1151-1166. doi: 10.1016/j.jcmg.2014.07.015

Bjork IC, Rozis E, Slordahl SA, Marwick TH. Incremental value of strain rate imaging to wall motion analysis for prediction of outcome in patients undergoing dobutamine stress echocardiography. Circulation 2007;115: 1252-9. doi:10.1161/CIRCULATIONAHA.106.640334

Schroeder J, Hamada S, Gründlinger N, Rubeau T, Altiok E, Ulbrich K, Keszei A, Marx N, Becker M. Myocardial deformation by strain echocardiography identifies patients with acute coronary syndrome and non-diagnostic ECG presenting in a chest pain unit: a prospective study of diagnostic accuracy. Clin Res Cardiol. 2015 Sep 8. [Epub ahead of print]

García-Álvarez, A., Sitges, M., Regueiro, A., Poyatos, S., Pinazo, M. J., Posada, E. Myocardial deformation analysis in Chagas heart disease with the use of speckle tracking echocardiography. J Card Fail 2011 17(12), 1028-1034. doi: 10.1016/j.cardfail.2011.08.007

Macedo, C. T., Larocca, T. F., Noya-Rabelo, M., Correia, L. C. L., Moreira, M. I., Caldas, A, Soares, M. B. P. Assessment of speckle tracking strain predictive value for myocardial fibrosis in subjects with Chagas disease.IJC Heart & Vasculature 2015;8:75-80. doi:10.1016/j.ijcha.2015.05.007

Debonnaire, P., Thijssen, J., Leong, D. P., Joyce, E., Katsanos, S., Hoogslag, G. E Marsan, N. A. Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients. Int J Card Imag 2015; 30(3): 549-558.

Kusumoto FM, Calkins H, Boehmer J, et al. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation 2014;130: 94–125. doi: 10.1007/s10554-014-0378-z

Ayub-Ferreira S, Mangini S, Issa V, Cruz F, Bacal F, Guimaraes G, Conceicao-Souza G, Marcondes-Braga F, Bochi E. Mode of Death of Chagas Heart Disease. Comparison with other etiologies. A Subanalysis of the REMADHE trial. PLoS Negl Trop Dis. 2013 Apr 25;7(4):e2176. doi: 10.1371/journal.pntd.0002176

Hundley W, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance. JACC 2010; 55: 2614–62. doi: 10.1161/CIR.0b013e3181d44a8f

Simonetti OP, Finn JP, White RD, et al. “Black blood” T2-weighted inversion-recovery MR imaging of the heart. Radiology. 1996;199:49–57.

Barkhausen J, Ruehm SG, Goyen M, et al. MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology. 2001;219:264 –9.

Andrade ZA, Andrade SG, Correa R, et al. Myocardial changes in acute Trypanosoma cruzi infection. Ultrastructural evidence of immune damage and the role of microangiopathy. Am J Pathol 1994; 144:1403.

Willerson JT, Scales F, Mukherjee A. Abnormal myocardial fluid retention as an early manifestation of ischemic injury. Am J Pathol. 1977;87:159 –88.

Bocchi E, Kalil R, Bacal F, Higuchi M, Meneghetu C, Magalhaes A, Belotti, Ramires J. Magnetic Resonance Imaging in Chronic Chagas' Disease: Correlation with Endomyocardial Biopsy Findings and Gallium-67 Cardiac Uptake. Echocardiography 1998:15(3);279-287

Rodríguez-Zanella H, Meléndez-Ramírez G, Velazquez L, Meave A, Alexanderson E. ECG score correlates with myocardial fibrosis assessed by magnetic resonance: A study in Chagas heart disease. International Journal of Cardiology 2015;187: 78–79. doi: 10.1016/j.ijcard.2015.03.337

Strauss DG, Cardoso S, Lima JA, Rochitte CE, Wu KC. ECG scar quantification correlates with cardiac magnetic resonance scar size and prognostic factors in Chagas’ disease. Heart 2011;97: 357–61. doi: 10.1136/hrt.2010.210047

Volpe G., Moreira H , Trad H, Wu K , Braggion-Santos MF , Koenigkam Santos M , Maciel B , Pazin A, Marin-Neto J , Lima JA , Andre Schmidt. Presence of scar by late gadolinium enhancement is a strong predictor of events in Chagas Heart Disease. J Cardiovasc Magn Reson. 2014; 16(Suppl 1): P343. doi:10.1186/1532-429X-16-S1-P343

Mello RP, Szarf G, Schvartzman PR, Nakano EM, Espinosa MM, Szejnfeld D, Fernandes V, Lima JA,Cirenza C, De Paola AA. Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas’ heart disease. Arq Bras Cardiol. 2012 May;98(5):421-30.

Neilan TG1, Coelho-Filho OR, Danik SB, Shah RV, Dodson JA, Verdini DJ, Tokuda M, Daly CA, Tedrow UB, Stevenson WG, Jerosch-Herold M, Ghoshhajra BB, Kwong RY. CMR Quantification of Myocardial Scar Provides Additive Prognostic Information in Nonischemic Cardiomyopathy. JACC Cardiovasc Imaging. 2013 Sep;6(9):944-54. doi: 10.1016/j.jcmg.2013.05.013

Iles L1, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ. Myocardial fibrosis predicts appropriate device therapy in patients with implantable Cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011 Feb 15;57(7):821-8. doi: 10.1016/j.jacc.2010.06.062.

Marin-Neto JA, Marzullo P, Mar- cassa C, et al. Myocardial perfusion abnormalities in chronic Chagas’ disease as detected by thallium-201 scintigraphy. Am J Cardiol 1992;69: 780–4.

Simões MV, Pintya AO, Bromberg-Marin G, Sarabanda AV, Antloga CM, Pazin-Filho A et al. (2000) Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas’ cardiomyopathy. Am J Cardiol 86:975–981.

Hiss FC, Lascala TF, Maciel BC, Marin-Neto A, Simões MV. Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas’ cardiomyopathy. J Am Coll Cardiol Img 2008; 2:164 –72. 10.1016/j.jcmg.2008.09.012.

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4




DOI: https://doi.org/10.17987/icfj.v7i0.225

Comments on this article

View all comments


Copyright (c) 2016 Hugo Rodriguez-Zanella, Jose Luis Salas-Pacheco, Gabriela Melendez-Ramirez, Jose Antonio Arias-Godínez, Nydia Avila-Vanzzinni, Maria Eugenia Ruiz-Esparza, Juan Francisco Fritche Salazar, Jesus Antonio Blanco Figueroa, Erick Alexánderson-Rosas

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.